ImmuCell Corporation Investor Presentation April 2024

ImmuCell Corporation (NASDAQ: ICCC) presents its business overview, strategic opportunities, and financial performance for April 2024. The presentation covers company operations, product development including First Defense and Re-Tain product lines, manufacturing capacity expansion, and market positioning in animal health.